QuidelOrtho Corp SEC filings QDEL
QuidelOrtho Corp has 502 filings in SEC EDGAR's recent list, going back to Jan 31, 2022. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 28, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 27, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations, officer or director change). The company's fiscal year ends on January 1.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 3, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 23, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 23, 2026 | Jun 22, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2026 | Jun 16, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 15, 2026 | Apr 15, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 24, 2026 | Mar 18, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 13, 2026 | Feb 9, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 11, 2026 | Feb 11, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 5, 2026 | Jan 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Aug 21, 2025 | Aug 21, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 27, 2025 | May 20, 2025 |
| 8-K |
Current report
Results of operations
|
May 7, 2025 | May 7, 2025 |
| 8-K |
Current report
Auditor change
|
Mar 4, 2025 | Feb 28, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 12, 2025 | Feb 12, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 10, 2024 | Dec 6, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Nov 21, 2024 | Nov 19, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 18, 2024 | Nov 18, 2024 |
| 8-K/A |
Amended current report
Officer or director change
|
Nov 18, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 8, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Results of operations
|
Jul 31, 2024 | Jul 31, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 17, 2024 | May 14, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 7, 2024 | May 1, 2024 |
| 8-K |
Current report
Material agreement
|
Apr 29, 2024 | Apr 25, 2024 |
| 8-K/A |
Amended current report
Officer or director change
|
Feb 29, 2024 | Feb 14, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 21, 2024 | Feb 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 16, 2024 | Feb 16, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 13, 2024 | Feb 13, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 1, 2023 | Nov 27, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 1, 2023 | Nov 1, 2023 |
| 8-K |
Current report
Results of operations
|
Oct 12, 2023 | Oct 12, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 18, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 19, 2023 | May 16, 2023 |
| 8-K |
Current report
Results of operations
|
May 3, 2023 | May 3, 2023 |
| 8-K |
Current report
Results of operations
|
Apr 13, 2023 | Apr 13, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 10, 2023 | Apr 4, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 15, 2023 | Feb 15, 2023 |
| 8-K |
Current report
Results of operations
|
Jan 6, 2023 | Jan 6, 2023 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Dec 13, 2022 | Dec 8, 2022 |
| 8-K |
Current report
Other events
|
Dec 5, 2022 | Dec 5, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2022 | Nov 2, 2022 |
| 8-K |
Current report
Results of operations
|
Oct 12, 2022 | Oct 12, 2022 |
| 8-K |
Current report
Other events
|
Aug 17, 2022 | Aug 17, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 7, 2022 | Jul 7, 2022 |
| 8-K |
Current report
Officer or director change
|
Jun 6, 2022 | May 31, 2022 |
Showing 54 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- QDEL (Nasdaq)
- Fiscal year ends
- January 1
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1906324
- Former names
- Coronado Topco, Inc. (until Apr 11, 2022)
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
- Alpha Teknova, Inc. TKNO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.